Abstract

Title

Pulmonary Endarterectomy in Patients with Chronic Thromboembolic Pulmonary Hypertension: The Singapore Experience

Type
Free Paper Session 3
Theme
ACC Asia & SCS 32nd Annual Scientific Meeting
Topic
Non-Invasive Cardiac Imaging, Echocardiography, Nuclear Cardiology / Adult Congenital Heart Disease / Cardiac Surgery

Authors

Main Author
Alicia Chia1
Presenting Author
Alicia Chia1
Co-Author
Jonathan Yap 2
Wen Ruan2
Ju Le Tan2
Kenny Loh3
Ming Huat Goh3
Narayan Lath4
Foong Koon Cheah4
Ghee Chee Phua5
Duu Wen Sewa5
Aileen Ang6
Lai Heng Lee6
Mee Yong Loi1
Tanee Chan1
Kelvin Quah2
Adila binte Ismail2
Soo Teik Lim 2
David Jenkins7
Victor Chao1

Authors' Institution

Department / Institution / Country
Cardiothoracic Surgery / National Heart Centre Singapore / Singapore1
Cardiology / National Heart Centre Singapore / Singapore2
Anaesthesia / Singapore General Hospital / Singapore3
Radiology / Singapore General Hospital / Singapore4
Respiratory Medicine / Singapore General Hospital / Singapore5
Haematology / Singapore General Hospital / Singapore6
Cardiothoracic Surgery / Royal Papworth Hospital / United Kingdom7
Content
Objective(s)

Chronic thromboembolic pulmonary hypertension (CTEPH) is a debilitating condition that portends significant mortality and morbidity. Pulmonary endarterectomy (PEA) has been shown to be an efficacious treatment of this chronic disease. We aim to describe our local experience with this treatment modality.

Material and Method

All consecutive CTEPH patients who underwent PEA at our single tertiary cardiac institution from Jun 2015 to Dec 2018 were included. Baseline clinical characteristics and procedure details were collected. Efficacy outcomes studied included reduction in pulmonary pressures and resistance and improvements in functional status. Safety outcomes studied included peri-operative complications and mortality.


 
Result(s)

A total of 16 patients (mean age 54.8 ± 9.9 years; 6 males) underwent PEA. 2 of the 4 patients (25%) from the initial series passed away in-hospital after the PEA due to right heart failure. The NHCS CTEPH team subsequently went for a team HMDP at the Royal Papworth Hospital in UK. There were no subsequent mortalities in the last consecutive 12 patients. One patient required temporary ECMO support for reperfusion lung injury but was successfully weaned off. Seven incidental cases of SDH were noted on routine CT Brain scan post PEA (1 required burrhole drainage, the rest were conservatively treated). In the remaining 14 patients, NYHA functional class improved in all to NYHA I-II at 3 to 6 months (p=0.003), and this improvement was sustained in the majority at 1 to 2 years of follow-up (p=0.011). There was significant reduction in pulmonary vascular resistance from 11.68±5.38 Woods pre-treatment to 4.06±3.68 Woods (p<0.001) post-treatment, as well as in mean pulmonary artery pressure from 49.2±7.07mmHg to 30.5±16.9mmHg post-treatment (p<0.001).

Conclusion

PEA is a complex surgery that requires both good surgical technique as well as a comprehensive multi-disciplinary team care approach. Beyond the initial learning curve and with greater experience, the team has since achieved consistently improved outcomes.

Keywords: Chronic Thromboembolic Pulmonary Hypertension; CTEPH; Pulmonary Endarterectomy; PEA
Requires Audio or Video system for Presentation?: Yes Back